Extended spectrum β-lactamases among gram-negative bacterial isolates from clinical specimens in three major hospitals in Northern Jordan

International Journal of Microbiology

Volumn , Issue , 2009, Pages

  Batchoun, Raymond G ^a   Swedan, Samer F ^a   Shurman, Abdullah M ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 77952402539     PISSN: 1687918X     EISSN: 16879198     Source Type: Journal    
DOI: 10.1155/2009/513874     Document Type: Article

References (35)

1. R. Bonnet, C. De Champs, D. Sirot, C. Chanal, R. Labia, and J. Sirot, "Diversity of TEM mutants in Proteus mirabilis, " Antimicrobial Agents and Chemotherapy, vol. 43, no. 11, pp. 2671-2677, 1999. (Pubitemid 29519546)
2. G. Arlet, G. Brami, D. Decrere, et al., "Molecular characterization by PCR-restriction fragment length polymorphism of TEM β-lactamases, " FEMS Microbiology Letters, vol. 134, pp. 1498-1500, 1995.
3. J. Blazquez, M. I. Morosini, M.-C. Negri, and F. Baquero, "Selection of naturally occurring extended-spectrum TEM β- lactamase variants by fluctuating β-lactam pressure, " Antimicrobial Agents and Chemotherapy, vol. 44, no. 8, pp. 2182- 2184, 2000. (Pubitemid 30484448)
4. J. Walther-Rasmussen and N. Høiby, "Plasmid-borne AmpC β-lactamases, " Canadian Journal of Microbiology, vol. 48, no. 6, pp. 479-493, 2002.
5. G. Arlet and A. Philippon, " Construction by polymerase chain reaction and intragenic DNA probes for three main types of transferable β-lactamases (TEM, SHV, CARB), " FEMS Microbiology Letters, vol. 82, pp. 19-26, 1991.
6. A. Bauernfeind, I. Stemplinger, R. Jungwirth, S. Ernst, and J. M. Casellas, "Sequences of β-Lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases, " Antimicrobial Agents and Chemotherapy, vol. 40, pp. 509-513, 1996. (Pubitemid 26049373)
7. W. -L. Yu, Y. -C. Chuang, and J. Walther-Rasmussen, "Extended- spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control, " Journal of Microbiology, Immunology and Infection, vol. 39, no. 4, pp. 264-277, 2006. (Pubitemid 44682772)
8. S. H. Choi, J. E. Lee, S. J. Park, et al., "Prevalence, microbiology, and clinical characteristics of extended-spectrum β-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea, " European Journal of Clinical Microbiology and Infectious Diseases, vol. 26, no. 8, pp. 557-561, 2007. (Pubitemid 47106801)
9. D. Ivanova, R. Markovska, N. Hadjieva, I. Schneider, I. Mitov, and A. Bauernfeind, "Extended-spectrum β-lactamaseproducing Serratia marcescens outbreak in a Bulgarian hospital, " Journal of Hospital Infection, vol. 70, no. 1, pp. 60-65, 2008.
10. R. Bonnet, J. L. M. Sampaio, C. Chanal, et al., "A novel class A extended-spectrum β-lactamase (BES-1) in Serratia marcescens isolated in Brazil, " Antimicrobial Agents and Chemotherapy, vol. 44, no. 11, pp. 3061-3068, 2000.
11. J. J. Jean, P. R. Hsueh, W. S. Lee, et al., "Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan, " European Journal of Clinical Microbiology and Infectious Diseases, vol. 28, no. 2, pp. 215- 220, 2009.
12. J. Färber, K. A. Moder, F. Layer, I. Tammer, W. König, and B. König, "Extended-spectrum beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium, " Journal of Clinical Microbiology, vol. 46, no. 11, pp. 3721-3727, 2008.
13. K. Bush, G. A. Jacoby, and A. A. Medeiros, "A functional classification scheme for β-lactamases and its correlation with molecular structure, " Antimicrobial Agents and Chemotherapy, vol. 39, no. 6, pp. 1211-1233, 1995.
14. F. H. M'Zali, A. Chanawong, K. G. Kerr, D. Birkenhead, and P. M. Hawkey, "Detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae: comparison of the MAST DD test, the double disk and the Etest ESBL, " Antimicrobial Agents and Chemotherapy, vol. 45, pp. 881-885, 2000. (Pubitemid 30348961)
15. R. A. Bonomo, S. A. Rudin, and D. M. Shlaes, "Tazobactam is a potent inactivator of selected inhibitor-resistant class A β- lactamases, " FEMS Microbiology Letters, vol. 148, no. 1, pp. 59- 62, 1997. (Pubitemid 27128357)
16. P. A. Bradford, Y. Yang, D. Sahm, I. Grope, D. Gardovska, and G. Storch, "CTX-M-5, a novel cefotaxime-hydrolyzing β- Lactamase from an out-break of Salmonella typhimurium in Latvia, " Antimicrobial Agents and Chemotherapy, vol. 42, pp. 1980-1894, 1998.
17. C. Branger, A. L. Lesimple, B. Bruneau, P. Berry, and N. Lambert-Zechovsky, "Long-term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases in a university hospital, " Journal of Medical Microbiology, vol. 47, no. 3, pp. 201-209, 1998. (Pubitemid 28090049)
18. P. L. Ho, D. N. C. Tsang, T. L. Que, M. Ho, and K. Y. Yuen, "Comparison of screening methods for detection of extended-spectrum β-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong, " APMIS, vol. 108, no. 3, pp. 237-240, 2000. (Pubitemid 30159005)
19. H. Pai, S. Lyu, J. H. Lee, J. Kim, Y. Kwon, J.-W. Kim, and K.W. Choe, "Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea, " Journal of Clinical Microbiology, vol. 37, no. 6, pp. 1758-1763, 1999. (Pubitemid 29235219)
20. T. Yagi, H. Kruokawa, N. Shibata, K. Shibayama, and Y. Arakawa, "A preliminary survey of extended-spectrum β- lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan, " FEMS Microbiology Letters, vol. 184, pp. 53-56, 2000. (Pubitemid 30109579)
21. J. J. Yan, S. M.Wu, S. H. Tsai, J. J.Wu, and I. J. Su, "Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrumβ-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan, " Antimicrobial Agents and Chemotherapy, vol. 44, pp. 1438- 1442, 2000.
22. J. K. Rasheed, C. Jay, B. Metchock, et al., "Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia, " Antimicrobial Agents and Chemotherapy, vol. 41, pp. 647-653, 1997. (Pubitemid 27098419)
23. E. W. Koneman, S. D. Allen, W. M. Janda, P. C. Schreckenberger, and W. C. winn, Color Atlas and Textbook of Diagnostic Microbiology, JB Lippincott, Philadelphia, Pa, USA, 4th edition, 1992.
24. P. R. Murray, E. J. Baron, M. A. Pfaller, et al., Eds., Manual of Clinical Microbiology, American Society for Microbiology, Washington, DC, USA, 7th edition, 1999.
25. E. J. Baron and S. M. Finegold, "Methods for testing antimicrobial effectiveness, " in Baily & Scott's Diagnostic Microbiology, pp. 171-194, The C.V. Mosby Company, St. Louis, Mo, USA, 1990.
26. D. G. Evans, D. J. Evans, and H. L. DuPont, "Virulence factors of Enterotoxigenic Escherichia coli, " The Journal of Infectious Diseases, vol. 136, pp. S118-S123, 1977. (Pubitemid 8171410)
27. National Committee for Clinical Laboratory Standards, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, " Approved standard M7-A5 and informational supplement M100-S10, National Committee for Clinical Laboratory Standards, Wayne, Pa, USA, 2000.
28. V. Jarlier, M. H. Nicolas, G. Fournier, and A. Philippon, "Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns, " Reviews of Infectious Diseases, vol. 10, no. 4, pp. 867-878, 1988.
29. M. T. Youssef, H. I. Malkawi, A. A. Shurman, and A. O. Andremont, "Molecular typing of multiresistant Klebsiella pneumoniae isolated from children from northern Jordan, " Journal of Tropical Pediatrics, vol. 45, no. 5, pp. 271-277, 1999. (Pubitemid 29495784)
30. A. A. Shehabia, A. Mahafzah, I. Baadran, F. A. Qadar, and N. Dajani, "High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum β-lactam drugs in intensive care units, " Diagnostic Microbiology and Infectious Disease, vol. 36, no. 1, pp. 53-56, 2000. (Pubitemid 30085487)
31. P. A. Bradford, "Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat, " Clinical Microbiology Reviews, vol. 14, no. 4, pp. 933-951, 2001. (Pubitemid 32979636)
32. T. Spanu, F. Luzzaro, M. Perilli, et al., "Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β- lactams and other antimicrobial drugs, " Antimicrobial Agents and Chemotherapy, vol. 46, no. 1, pp. 196-202, 2002. (Pubitemid 34031625)
33. H.Wang, S. Kelkar, W.Wu, M. Chen, and J. P. Quinn, "Clinical isolates of Enterobacteriaceae producing extended-spectrumβ- lactamases: prevalence of CTX-M-3 at a hospital in China, " Antimicrobial Agents and Chemotherapy, vol. 47, no. 2, pp. 790-793, 2003. (Pubitemid 36158117)
34. A. A. Kader and K. Angamuthu, "Extended-spectrum β- lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia, " Saudi Medical Journal, vol. 26, no. 6, pp. 956-959, 2005. (Pubitemid 41015082)
35. E. M. Mokaddas, A. A. Abdulla, S. Shati, and V. O. Rotimi, "The technical aspects and clinical significance of detecting extended-spectrum β-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait, " Journal of Chemotherapy, vol. 20, no. 4, pp. 445-451, 2008.